111 related articles for article (PubMed ID: 30391671)
21. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
22. DNA copy number gain-mediated lncRNA LINC01061 upregulation predicts poor prognosis and promotes papillary thyroid cancer progression.
Wu X; Yan Y; Li H; Ji N; Yu T; Huang Y; Shi W; Gao L; Ma L; Hu Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):1247-1253. PubMed ID: 30029886
[TBL] [Abstract][Full Text] [Related]
23. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
25. ERK-dependent downregulation of Skp2 reduces Myc activity with HGF, leading to inhibition of cell proliferation through a decrease in Id1 expression.
Li X; Bian Y; Takizawa Y; Hashimoto T; Ikoma T; Tanaka J; Kitamura N; Inagaki Y; Komada M; Tanaka T
Mol Cancer Res; 2013 Nov; 11(11):1437-47. PubMed ID: 24177224
[TBL] [Abstract][Full Text] [Related]
26. Disruption of MEK/ERK/c-Myc signaling radiosensitizes prostate cancer cells in vitro and in vivo.
Ciccarelli C; Di Rocco A; Gravina GL; Mauro A; Festuccia C; Del Fattore A; Berardinelli P; De Felice F; Musio D; Bouché M; Tombolini V; Zani BM; Marampon F
J Cancer Res Clin Oncol; 2018 Sep; 144(9):1685-1699. PubMed ID: 29959569
[TBL] [Abstract][Full Text] [Related]
27. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
Marampon F; Ciccarelli C; Zani BM
Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
[TBL] [Abstract][Full Text] [Related]
28. Dermatopontin promotes adhesion, spreading and migration of cardiac fibroblasts in vitro.
Liu X; Meng L; Shi Q; Liu S; Cui C; Hu S; Wei Y
Matrix Biol; 2013 Jan; 32(1):23-31. PubMed ID: 23262218
[TBL] [Abstract][Full Text] [Related]
29. Fibulin-5 inhibits Wnt/β-catenin signaling in lung cancer.
Chen X; Song X; Yue W; Chen D; Yu J; Yao Z; Zhang L
Oncotarget; 2015 Jun; 6(17):15022-34. PubMed ID: 25909283
[TBL] [Abstract][Full Text] [Related]
30. CircRNA circ-ITCH suppresses papillary thyroid cancer progression through miR-22-3p/CBL/β-catenin pathway.
Wang M; Chen B; Ru Z; Cong L
Biochem Biophys Res Commun; 2018 Sep; 504(1):283-288. PubMed ID: 30190130
[TBL] [Abstract][Full Text] [Related]
31. Dermatopontin in Skeletal Muscle Extracellular Matrix Regulates Myogenesis.
Kim T; Ahmad K; Shaikh S; Jan AT; Seo MG; Lee EJ; Choi I
Cells; 2019 Apr; 8(4):. PubMed ID: 30970625
[TBL] [Abstract][Full Text] [Related]
32. TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway.
Zheng Z; Zhou X; Cai Y; Chen E; Zhang X; Wang O; Wang Q; Liu H
Endocr Pathol; 2018 Dec; 29(4):310-316. PubMed ID: 30251060
[TBL] [Abstract][Full Text] [Related]
33. Bufalin inhibits pancreatic cancer by inducing cell cycle arrest via the c-Myc/NF-κB pathway.
Liu X; Xiao XY; Shou QY; Yan JF; Chen L; Fu HY; Wang JC
J Ethnopharmacol; 2016 Dec; 193():538-545. PubMed ID: 27686271
[TBL] [Abstract][Full Text] [Related]
34. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1.
Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J
Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060
[TBL] [Abstract][Full Text] [Related]
35. Dermatopontin, a shell matrix protein gene from pearl oyster Pinctada martensii, participates in nacre formation.
Jiao Y; Wang H; Du X; Zhao X; Wang Q; Huang R; Deng Y
Biochem Biophys Res Commun; 2012 Aug; 425(3):679-83. PubMed ID: 22842462
[TBL] [Abstract][Full Text] [Related]
36. miR-718 is involved in malignancy of papillary thyroid cancer through repression of PDPK1.
Wang X; Qi M
Pathol Res Pract; 2018 Nov; 214(11):1787-1793. PubMed ID: 30166214
[TBL] [Abstract][Full Text] [Related]
37. MiR-128 suppresses the growth of thyroid carcinoma by negatively regulating SPHK1.
Cao XZ; Bin H; Zang ZN
Biomed Pharmacother; 2019 Jan; 109():1960-1966. PubMed ID: 30551451
[TBL] [Abstract][Full Text] [Related]
38. DUSP5 and DUSP6, two ERK specific phosphatases, are markers of a higher MAPK signaling activation in BRAF mutated thyroid cancers.
Buffet C; Hecale-Perlemoine K; Bricaire L; Dumont F; Baudry C; Tissier F; Bertherat J; Cochand-Priollet B; Raffin-Sanson ML; Cormier F; Groussin L
PLoS One; 2017; 12(9):e0184861. PubMed ID: 28910386
[TBL] [Abstract][Full Text] [Related]
39. Expression and integrity of dermatopontin in chronic cutaneous wounds: a crucial factor in impaired wound healing.
Krishnaswamy VR; Manikandan M; Munirajan AK; Vijayaraghavan D; Korrapati PS
Cell Tissue Res; 2014 Dec; 358(3):833-41. PubMed ID: 25260909
[TBL] [Abstract][Full Text] [Related]
40. RASSF10 is Epigenetically Inactivated and Suppresses Cell Proliferation and Induces Cell Apoptosis by Activating the p53 Signalling Pathway in Papillary Thyroid Carcinoma Cancer.
Fan C; Wang W; Jin J; Yu Z; Xin X
Cell Physiol Biochem; 2017; 41(3):1229-1239. PubMed ID: 28268222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]